RETRACTED ARTICLE: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
- DOI
- 10.1186/s13045-020-00857-7
- Published
- 2020-03-26
- Container
- Journal of Hematology & Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13045-020-00857-7,
title = {RETRACTED ARTICLE: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression},
author = {Huajie Song and Dan Li and Xiaojing Wang and Erhu Fang and Feng Yang and Anpei Hu and Jianqun Wang and Yanhua Guo and Yang Liu and Hongjun Li and Yajun Chen and Kai Huang and Liduan Zheng and Qiangsong Tong},
year = {2020},
journal = {Journal of Hematology \& Oncology},
doi = {10.1186/s13045-020-00857-7},
url = {https://doi.org/10.1186/s13045-020-00857-7}
}RIS
TY - JOUR TI - RETRACTED ARTICLE: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression AU - Huajie Song AU - Dan Li AU - Xiaojing Wang AU - Erhu Fang AU - Feng Yang AU - Anpei Hu AU - Jianqun Wang AU - Yanhua Guo AU - Yang Liu AU - Hongjun Li AU - Yajun Chen AU - Kai Huang AU - Liduan Zheng AU - Qiangsong Tong PY - 2020 JO - Journal of Hematology & Oncology DO - 10.1186/s13045-020-00857-7 UR - https://doi.org/10.1186/s13045-020-00857-7 ER -
APA
Song, H., Li, D., Wang, X., Fang, E., Yang, F., Hu, A., Wang, J., Guo, Y., Liu, Y., Li, H., Chen, Y., Huang, K., Zheng, L., & Tong, Q. (2020). RETRACTED ARTICLE: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-020-00857-7
Source records
- crossref · retrieved 2026-11-07T09:16:59.689Z